Arthur T. Sands

Insider Reports History

Entity
Individual
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Arthur T. Sands
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arthur T. Sands:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nurix Therapeutics, Inc. President, CEO, Director Employee Stock Option (right to buy) 800K Feb 13, 2024 Direct

Insider Reports Filed by Arthur T. Sands

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRIX Nurix Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 President, CEO, Director
NRIX Nurix Therapeutics, Inc. Feb 14, 2023 1 $0 4 Feb 15, 2023 President, CEO, Director
NRIX Nurix Therapeutics, Inc. Aug 9, 2022 1 $0 4 Aug 10, 2022 President, CEO, Director
NRIX Nurix Therapeutics, Inc. Jan 20, 2022 1 $0 4 Jan 21, 2022 President, CEO, Director